Back to Blackstone Inc.

SYRE
Showing 8 of 10 quarters

Position history for Blackstone Inc.'s holdings in SPYRE THERAPEUTICS INC

Blackstone Inc. holds 292,847 shares of SYRE (SPYRE THERAPEUTICS INC), worth $14.8M as of 2026-Q1. The position was decreased (-41.5% shares). SYRE represents 0.1% of Blackstone Inc.'s portfolio.

Current Value

$14.8M

Current Shares

292,847

Total Value Change

+$7.9M

Total Shares Change

-148

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
292,847
-41.5%
$14.8M0.1%$40.07
0
2025-Q4
Unchanged
500,998
0.0%
$16.4M0.1%$31.88
0
2025-Q3
Increased
500,998
+2.4%
$8.4M0.0%$16.36
28
2025-Q2
Unchanged
489,248
0.0%
$7.3M0.0%$15.22
0
2025-Q1
Increased
489,248
+8.9%
$7.9M0.0%$17.94
30
2024-Q4
Increased
449,201
+53.3%
$10.5M0.0%$22.54
39
2024-Q3
Unchanged
292,995
0.0%
$8.6M0.0%$28.49
0
2024-Q2
Increased
292,995
+1365.6%
$6.9M0.0%$23.51
44

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used